Medicare Planning to Adopt CDC Opioid Guidelines — Pain News Network – February 03, 2017 – By Pat Anson, Editor
The Centers for Medicare and Medicaid Services (CMS) has announced plans to fully implement the opioid prescribing guidelines released by the Centers for Disease Control and Prevention, which recommend that doctors not prescribe opioid medication for chronic non-cancer pain.
CMS is taking the CDC’s voluntary guidelines one step further, however, by mandating them as official Medicare policy and taking punitive action against doctors and patients who don’t follow them.
As Pain News Network has reported, CMS is adopting a “Big Brother” approach to fighting opioid abuse by developing a strategy that will encourage pharmacists to report doctors who may be overprescribing opioids and patients who may be abusing them. Continue reading
21st Century Cures Act Draws Concern Over Possible Lowered Clinical Standards – Pain Medicine News – Dec 13, 2016
The 21st Century Cures Act, a bill that could accelerate the drug approval process and increase funding for mental health care, drug addiction treatment and biomedical research, has been passed by a Senate vote of 94-5
Despite concerns that the bill may be more beneficial to pharmaceutical companies than to consumers, President Barack Obama is expected to sign the bill into law, after which the FDA, the National Institutes of Health (NIH), and the Department of Health and Human Services will be responsible for its implementation Continue reading
What Is the Truth About Overdose Deaths? by Dr. Lynn Webster
In its 2015 Report Overview, the Clinton Foundation calls prescription drug abuse (leading to overdose) an imminent public health threat that kills “more people than motor vehicle accidents.”
The CDC reports that, during 2014, a total of 47,055 drug overdose deaths occurred in the United States.
But this number has been artificially manipulated and inflated to cause more alarm about our pain medications.
The article goes on to explain two huge and obvious flaws: Continue reading
Your Voice Matters – Make Chronic Pain Visible
WHY WOULD TELLING MY STORY AND SENDING A LETTER MAKE A DIFFERENCE?
The National Fibromyalgia & Chronic Pain Association and pain patient organizations were recently asked to reach out to people with pain and their families directly to ask about their experiences.
People making decisions that significantly affect your quality of life (federal officials, legislators and policy makers) need to know if you are receiving adequate pain management and relief.
Telling your story can affect their policy decisions and new areas of research. Continue reading
CDC Scientists Expose Agency Corruption – Nov. 21, 2016 – Robert F. Kennedy, Jr.
Last month, The Hill published a letter [see below] sent by “more than a dozen” senior Center for Disease Control (CDC) scientists charging the agency with nursing an atmosphere of pervasive research fraud.
The letter to CDC Chief of Staff, Carmen Villar, expressed alarm “about the current state of ethics at our agency.”
The scientists complained that “our mission is being influenced and shaped by outside parties and rogue interests” and “circumvented by some of our leaders.”
The scientists told Villar that, “questionable and unethical practices, occurring at all levels and in all of our respective units, threaten to undermine our credibility and reputation as a trusted leader in public health.” Continue reading
State Legal Restrictions and Prescription-Opioid Use among Disabled Adults — NEJM
In response to rising rates of opioid abuse and overdose, U.S. states enacted laws to restrict the prescribing and dispensing of controlled substances.
The effect of these laws on opioid use is unclear.
Despite the exhortations to use only evidence-based methods, it’s a remarkable oversight that the effects of all these restrictions has never been studied.
I suspect PROP is trying their best to avoid this because they know the results won’t bear out their biased and prejudiced predictions. Continue reading
Lawmakers urge DEA to reconsider ‘hasty’ ban of opioid-like kratom – By Eric Boodman @ericboodman September 23, 2016
When the Drug Enforcement Administration announced in late August that it would outlaw an opioid-like plant called kratom, the reaction was immediate.
Kratom sellers threatened legal action.
Over 130,000 people signed a petition to stop the ban. Some 400 users marched in front of the White House, with kids wearing shirts that said, “Kratom saved my mom.”
Now members of Congress are getting involved. Continue reading
Kratom Movement Draws Attention From Congress, And More On The DEA’s Plan To Schedule 1
The DEA’s deadline for placing kratom alkaloids on the schedule 1 controlled substance list grows closer, and the outpouring of support for the ancient plant grows louder.
More than 130,000 people have signed a petition on WhiteHouse.gov to keep kratom legal. The effort is drawing attention in high places.
Two congressmen have penned a “dear colleague letter” asking that the DEA ”delay a final decision on the placement of kratom as a schedule I [and]
provide ample time for public comment on this significant decision,”… which the agency has so far declined to do. Continue reading
Cannabinoid Receptor 2: Pain Treatment Without Tolerance or Withdrawal – reposted with edits from April 2015
This article about a promising new medicine derived from cannabis was published by the National Institute on Drug Abuse (NIDA), on their site “drugabuse.gov“. (Other branches of the same government, FDA and DEA, still classify cannabis as a Schedule I drug,)
Chronic cannabinoid receptor 2 activation reverses paclitaxel neuropathy without tolerance or cannabinoid receptor 1-dependent withdrawal.
The treatment of cancer pain is often among the approved uses of medical cannabis in states where it is legal. Continue reading
New analysis recommends responsible prescription of opioids to pain patients — ScienceDaily – July 13, 2016
Here’s an unusual article in a science-based publication suggesting the media disregards the facts to sensationalize the “opioid epidemic”.
Finally, there are voices of reason pushing back against the cruelty of the drug-war directed at pain patients.
A recent review and analysis suggests that some policies restricting opioid prescriptions to curb overdose deaths could be harming those who need them the most: pain patients. Continue reading